法拉第未来将通过私募配售投资QLGN的普通股和优先股

Core Insights - Faraday Future (FF) has signed a securities purchase agreement with Nasdaq-listed Qualigen Therapeutics, Inc. (Nasdaq: QLGN) to invest in QLGN's common and preferred stock through a private investment in public equity (PIPE) [1] - Following shareholder approval, QLGN will be renamed CXC10 and will focus entirely on cryptocurrency and Web3 ecosystem development [1] Group 1 - FF will collaborate with QLGN to develop cryptocurrency and Web3 business initiatives [1] - The investment marks a strategic move for FF to diversify its business interests into the growing Web3 sector [1]